Skip to Content
Merck
CN

MAB8252

Sigma-Aldrich

Anti-Influenza A Antibody, H-1 Antigen, clone 58AB7-19-18

clone 58AB7-19-18, Chemicon®, from mouse

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

Quality Level

300

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

58AB7-19-18, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG1

shipped in

wet ice

Immunogen

Epitope: H-1 Antigen
Influenza blend.

Application

Detect Influenza A using this Anti-Influenza A Antibody, H-1 Antigen, clone 58AB7-19-18 validated for use in IF.
Indirect Immunofluorescence : 1:50

Optimal working dilutions must be determined by the end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Influenza A H1 antigen.
• Reacts strongly with the following H1N1 strains:
A/Taiwan/1/86, A/USSR/90/77, and all CA strains 1986 to present.
• Does not react well with A/Texas/36/91; or the New Caledonia strain (after 1998).
• No reactivity shown to the following H3N2 strains:
A/Wuhan/396/95; A/Johannesburg/33/94; A/Shandung/93;A/Shanghai/16/89.
• No reactivity shown to Influenza B strains.

Physical form

Format: Purified
Purified immunoglobulin. Liquid in 0.02M PB with 0.25M NaCl, pH=7.6, 0.1% Sodium azide as a preservative.

Preparation Note

Maintain at 2-8°C for up to 12 months.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Influenza A H9N2: aspects of laboratory diagnosis.
Peiris, M; Yam, WC; Chan, KH; Ghose, P; Shortridge, KF
Journal of Clinical Microbiology null
The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells.
Xing Cheng,Qi Xu,Eyun Song,Chin-Fen Yang,George Kemble,Hong Jin
Virology null
Effectiveness of reverse transcription-PCR, virus isolation, and enzyme-linked immunosorbent assay for diagnosis of influenza A virus infection in different age groups.
Christoph Steininger, Michael Kundi, Stephan W Aberle, Judith H Aberle, Theresia Popow-Kraupp
Journal of Clinical Microbiology null
Christoph Steininger et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36(5), 567-574 (2003-02-21)
Twenty-one patients aged 4-78 years with influenza A virus-associated acute encephalopathy were studied. Influenza A virus could be detected only in a cerebrospinal fluid (CSF) specimen obtained from 1 of 18 patients, despite the use of a highly sensitive polymerase

Articles

默克抗原检测_传染病抗体-默克生命科学

呼吸道传染病由于其传染性强、传播速度快且发病率高，已成为我国重点防治的一类疾病。目前呼吸道病原体检测方法主要分为血清特异性抗体检测、抗原检测、多重核酸检测以及微生物检测系统。其中，相比于抗体检测，抗原检测在感染病毒初期、出现症状后即可做出检测，适用于疾病的早期诊断，对患者的治疗具有重要指导意义。

Related Content

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service